Wearable Health Solutions Inc. announced inclusion to Next Realm AI research lab to explore development of healthcare IoT solutions utilizing data analytics and artificial intelligence (AI).
Tag Archive for: Artificial Intelligence (AI)
The World Health Organization called for caution on Tuesday in using artificial intelligence for public healthcare, saying data used by AI to reach decisions could be biased or misused.
The pharmaceutical industry is expected to spend more than $3 billion on artificial intelligence by 2025 – up from $463 million in 2019. AI clearly adds value, but advocates say it is not yet living up to its potential.
BioNTech SE has agreed to acquire the British artificial intelligence (AI) startup InstaDeep for up to 562 million pounds ($682 million) to speed up its biotech research beyond COVID shots.
Managing regulatory information in the pharmaceutical industry is challenging in post-pandemic Europe. The introduction of new requirements surrounding substances, products, organizations, and referential (SPOR) data and a new shared target operating model (TOM) across Industry and regulators are forcing companies to rethink their approach to managing regulatory information and submissions. This is driving new data management initiatives to align existing regulatory data with master data systems, streamline data submissions, and improve data maintenance capabilities, according to Jens-Olaf Vanggaard, senior director, Global Safety, Regulatory & Quality Solutions, IQVIA.
Adopting digital transformation is now an industry standard for success – but what precisely does that mean for the clinical development landscape? Gary Shorter, Head of Artificial Intelligence at IQVIA, explores the answers.
As organizations continue to evaluate and implement automation and AI technology, it is important to consider how increased use of technology should align with both industry best practices and regulations – and to proactively address how technology adoption will impact stakeholders involved in routine pharmacovigilance activities while ensuring deployment and implementation poses no risk to breaching guidelines or regulations.
